Is there a Lao generic version of Capmatinib?
Capmatinib (Capmatinib) is indicated for the treatment of METPrimary tyrosine kinase overexpression (MET Patients with advanced or metastatic non-small cell lung cancer (NSCLC) with ex14skipping mutations or METincreased).
Capmatinib has a Laotian generic version. Capmatinib is not currently on the market in China, so patients cannot purchase it domestically. Capmatinib abroad is divided into original drugs and generic drugs. The original drug is mainly the original drug from Novartis, with a price of about 35,000 yuan and a specification of 200mg*60; the price of generic drugs is very cheap, mainly Laos generic drugs, with a price of about 3,000 to 4,000 yuan. The ingredients of original drugs and generic drugs are basically the same.
A specific explanation of indication means that the drug is approved to treat a specific type of disease. In this case, capmatinib is a targeted therapy that targets specific genetic mutations, primarily a specific type of mutation in theMETgene.
MET gene mutations or abnormal expression are common in some patients with non-small cell lung cancer, which may lead to abnormal proliferation and metastasis of tumor cells. The function of capmatinib is to inhibit the activity of MET kinase, thereby interfering with the growth and spread of tumor cells and achieving the purpose of treatment.
However, it is worth emphasizing that capmatinib is not suitable for all patients with non-small cell lung cancer, it is only suitable for patients with specific mutations in the MET gene. Relevant genetic testing is required before treatment to determine whether the patient is suitable for capmatinib treatment.
Like other drugs, capmatinib should be used strictly in accordance with your doctor's prescriptions and recommendations to ensure optimal efficacy and safety. If you or a loved one has non-small cell lung cancer and you have questions about whether capmatinib treatment is appropriate, please consult a medical professional for a detailed evaluation and advice.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)